Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-01-13 @ 7:46 AM
Study NCT ID:
NCT06614751
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-09-27
First Post:
2024-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
Sponsor:
Danatlas Pharmaceuticals Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-18
First Submit QC Date:
None
Study First Post Date:
2024-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-26
Last Update Post Date:
2024-09-27
Last Update Post Date Type:
ACTUAL